A prospective randomized controlled clinical trial to evaluate the efficacy and safety of Ayurvedic interventions in the management of COVID-19(Asymptomatic to moderate cases)

Shri Dhanwantry ayurevdic college and hospital0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•Asymptomatic to moderate cases registered in the Hospital, above 18 years of age of either gender, with COVID 2019 (Confirmed by Antigen test/ RT-PCR) quarantined at our hospital.
•2. Participants who can take medicines orally
•3. Patients willing to provide signed informed consent

•1.Patients suffering from severe COVID-19 Disease as judged by a physician
•2.Chronic, Severe, Unstable, Uncontrolled co-existent medical illness such as Diabetes, Hypertension, Cardiac disorders, liver, kidney disorders and lung disorders or other disease of concern which may put the patient at increased risk during the study
•3.Patients who are likely to worsen or planed ICU admission or ventilator support due to any reason
•4.Pregnancy and lactation
•5.Participation in a drug interventional clinical drug trial of any nature in the three month period preceding onset of COVID-19
•6.Participation in any other clinical trial of an experimental agent treatment for COVID-19
•7. Patients on any kind of Ayurveda treatment or any other alternative and complementary medicinal systems such as Homeopathy, Unani, Siddha and in particular requiring oral therapy of any kind.
•8.Physician decision that involvement in the study is not in the patientÂ´s best interest.

发起方

Shri Dhanwantry ayurevdic college and hospital